[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552247":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":15,"responsibleParty":31,"collaborators":7,"id":35,"slug":7,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":40,"eligibilityCriteria":41,"healthyVolunteers":36,"sex":42,"minAge":43,"maxAge":7,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":52,"overallStatus":18,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Scientific Institute San Raffaele","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":14},"Pierluigi Novellis, MD","CONTACT","+39022643","7202","novellis.pierluigi@hsr.it",[16],{"facility":17,"status":18,"city":19,"state":7,"zip":20,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"Scientific Institute Ospedale San Raffaele","RECRUITING","Milan","20132","Italy","IT",{"type":24,"coordinates":25},"Point",[26,27],9.18951,45.46427,{"lat":27,"lon":26},[30],{"name":10,"role":11,"phone":12,"phoneExt":13,"email":7},{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Pierluigi Novellis","MD","100552247",false,"NCT06470607","The Lymphocytic Infiltrate of Lung Tumors.","Biological Observational Monocentric Study Aimed at Analyzing the Lymphocytic Infiltrate of Lung Tumors","TREGILC","Inclusion Criteria:\n\n* Ability to provide informed consent;\n* Men and women over the age of 18;\n* Patients candidates for surgical treatment diagnosed with thoracic tumors\n\nExclusion Criteria:\n\n* Previous chemotherapy for any cancer within the last 6 months;\n* Pregnant and\u002For breastfeeding women;\n* Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive\u002Fimmunomodulatory treatments)","ALL","18 Years",{"count":45,"type":46},70,"ESTIMATED","OBSERVATIONAL","The study is configured as a monocentric observational transversal biological study.\n\nThe main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC).\n\nThe study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.",[50,51],"Lung Cancer","Immune System",[53,54,55],"thoracic tumors","Immune checkpoints","lymphocytes","2024-11-26",{"date":58,"type":59},"2024-11-29","ACTUAL",{"date":61,"type":59},"2023-01-20",{"date":63,"type":46},"2028-01-31",{"name":5,"class":6},1]